C
Pill imprint C has been identified as Mirtazapine 7.5 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.
Mirtazapine 7.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Mirtazapine Images
- Imprint:
-
C
- Strength:
- 7.5 mg
- Color:
- Yellow
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose monohydrate
corn starch
pregelatinized starch
silicon dioxide colloidal
magnesium stearate
ferric oxide yellow
hydroxypropyl cellulose
hypromellose 2910
titanium dioxide
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- 57664-0510
Advertisement
More Mirtazapine resources
- Mirtazapine (Wolters Kluwer)
- Mirtazapine Orally Disintegrating Tablets (Wolters Kluwer)
- mirtazapine (Cerner Multum)
- Remeron RD (Micromedex) - Includes Dosage Information
- mirtazapine (Micromedex) - Includes Dosage Information
- Mirtazapine (AHFS DI)
- Mirtazapine Orally Disintegrating Tablets (FDA)
- Mirtazapine Tablets (FDA)
- Remeron Tablets (FDA)
- Mirtazapine (Wolters Kluwer)
Search Again
